Go to Wolters Kluwer VitalLaw.comGo to Wolters Kluwer VitalLaw.com
VitalLaw®
  • Find answers to your questions
  • Log in to access your subscriptions
In depth. On point.
In depth. On point.
  • Home
  • Legal Directory
  • Home
  • Legal Directory
In depth. On point.
  • Articles
    • Articles
  • Law Firms
    • Law Firms
  • Organizations
    • Organizations
    • LABELING AND PACKAGING (FOOD, DRUGS & MEDICAL DEVICES)—N.D. Cal.: Baby food MDL is dismissed for lack of federal jurisdiction
    • ADMINISTRATION OF MEDICARE/MEDICAID PROGRAMS—DAB DECISIONS: Medicare reactivation effective date tied to receipt of approved revalidation application
      • You have 1 more complimentary views available this month. Log in if you are already a customer
    • CONTROLLED SUBSTANCES—FINAL RULES: DEA revokes exempted status for inactive butalbital products
      • You have 1 more complimentary views available this month. Log in if you are already a customer
    • ELECTRONIC HEALTH RECORDS—W.D. Ky.: Humana privacy lawsuit advances over alleged tracking of health information
      • You have 1 more complimentary views available this month. Log in if you are already a customer
    • EXPERT INSIGHTS—FDA opens applications for new pilot to shorten drug approval times: What sponsors need to know
      • You have 1 more complimentary views available this month. Log in if you are already a customer
    • FOOD SAFETY—FDA GUIDANCE NOTICES: FDA issues draft guidance on requirements for food traceability records
      • You have 1 more complimentary views available this month. Log in if you are already a customer
    • MEDICAL DEVICES—FINAL RULES: FDA classifies cell enrichment kit
      • You have 1 more complimentary views available this month. Log in if you are already a customer
    • PREEMPTION OF STATE LAW—1st Cir.: Seizure patient’s estate may amend complaint against Amgen about Aimovig biologic labeling
      • You have 1 more complimentary views available this month. Log in if you are already a customer
    • RURAL HEALTH CLINICS—GAO REPORTS: CMS awarded states $10 billion in RHT program funding
      • You have 1 more complimentary views available this month. Log in if you are already a customer
  • Articles
    • Articles
  • Law Firms
    • Law Firms
  • Organizations
    • Organizations

    Health Law Daily Wrap Up, PREEMPTION OF STATE LAW—1st Cir.: Seizure patient’s estate may amend complaint against Amgen about Aimovig biologic labeling, (Oct 15, 2026)

    Law Firms Mentioned:Cetrulo LLP | Dow Law Group, LLC | Hogan Lovells Cadwalader US LLP
    Organizations Mentioned:Amgen Inc. | Amgen USA Inc. | Novartis Institute for Biomedical Research, Inc.

    By Justin Marcus Smith, J.D.

    The court affirmed dismissal for “impossibility” preemption; however, amendment was not certainly futile because the estate made a presentation of newly acquired information forming a basis for a label change.

    A state law complaint about ...

    © 2026 CCH Incorporated and its affiliates and licensors. All rights reserved.

    • Manage Cookie Preferences
    • Privacy Statement
    • Terms of Use